Compounds are described of formula (1)
herein
m is 1 to 4;
n is zero, 1 or 2;
p is 1 to 4;
Z is a group CO2R1 where R1 is
(a) a hydrogen atom or an alkyl, phenalkyl or 2-naphthyl group;
(b) phenyl or substituted phenyl;
(c) -CH2COR5 where R5 is phenyl substituted phenyl or
2-naphthyl;
or Z is -CH2OH, -CHO or CONHR9 [where R9 is a hydrogen
atom or alkyl, aryl, -COR10 (where R10 is a hydrogen atom or an
alkyl or aryl group) Or -SO2R11 (where R11 is an alkyl or aryl
group)];
Y is substituted or unsubstituted 3-phenoxy-2-hydroxypropyl.
These compounds inhibit gastric acid secretion and provide gastrointestinal cytoprotection, and may be formulated for use in the treatment of ulcers.
式(1)所述化合物
其中
m 为 1 至 4
n 为零、1 或 2
p 为 1 至 4;
Z 是一个基团 CO2R1,其中 R1 是
(a) 氢原子或烷基、苯基或 2-
萘基;
(b) 苯基或取代的苯基;
(c) -CH2COR5 其中 R5 是被取代的苯基或
2-
萘基;
或 Z 是 -CH2OH、-CHO 或 CONHR9 [其中 R9 是氢原子或烷基、芳基或烷基]。
其中 R9 是氢原子或烷基、芳基、-COR10(其中 R10 是氢原子或烷基或芳基
或-SO2R11(其中 R11 是烷基或芳基
基团)];
Y 是取代或未取代的 3-苯氧基-2-羟基丙基。
这些化合物可抑制胃酸分泌,提供胃肠道细胞保护,可配制成治疗溃疡的药物。